Cover Image
市場調查報告書

AvidBiotics Corp.- 產品平台檢討

AvidBiotics Corp. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 289826
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
AvidBiotics Corp.- 產品平台檢討 AvidBiotics Corp. - Product Pipeline Review - 2015
出版日期: 2015年05月27日 內容資訊: 英文 20 Pages
簡介

AvidBiotics Corp.是總公司設立於美國的製藥企業。正從事以細菌,病毒,癌症細胞為目標的治療·預防用非抗體蛋白質的開發。同時也開發醫療保健,食物安全性用產品等。

本報告提供AvidBiotics Corp.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

AvidBiotics Corp.的基本資料

  • AvidBiotics Corp.概要
  • 主要資訊
  • 企業資料

AvidBiotics Corp.:R&D概要

  • 主要的治療範圍

AvidBiotics Corp.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

AvidBiotics Corp.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

AvidBiotics Corp.:藥物簡介

  • Recombinant Protein for Bladder Cancer, Myeloma, Lymphoma and CMV Infections
  • Recombinant Protein for Viral Infections
  • Recombinant Proteins to Disrupt Bacterial Cell Membrane for Bacterial Infections

AvidBiotics Corp.:開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

AvidBiotics Corp.:最近的開發平台資訊

AvidBiotics Corp.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07147CDB

Summary

Global Markets Direct's, 'AvidBiotics Corp. - Product Pipeline Review - 2015', provides an overview of the AvidBiotics Corp.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AvidBiotics Corp.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of AvidBiotics Corp. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of AvidBiotics Corp.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the AvidBiotics Corp.'s pipeline products

Reasons to buy

  • Evaluate AvidBiotics Corp.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of AvidBiotics Corp. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the AvidBiotics Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of AvidBiotics Corp. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of AvidBiotics Corp.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of AvidBiotics Corp. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • AvidBiotics Corp. Snapshot
    • AvidBiotics Corp. Overview
    • Key Information
    • Key Facts
  • AvidBiotics Corp. - Research and Development Overview
    • Key Therapeutic Areas
  • AvidBiotics Corp. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • AvidBiotics Corp. - Pipeline Products Glance
    • AvidBiotics Corp. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • AvidBiotics Corp. - Drug Profiles
    • Recombinant Protein for Bladder Cancer, Myeloma, Lymphoma and CMV Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Protein for Viral Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Proteins to Disrupt Bacterial Cell Membrane for Bacterial Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • AvidBiotics Corp. - Pipeline Analysis
    • AvidBiotics Corp. - Pipeline Products by Target
    • AvidBiotics Corp. - Pipeline Products by Molecule Type
    • AvidBiotics Corp. - Pipeline Products by Mechanism of Action
  • AvidBiotics Corp. - Recent Pipeline Updates
  • AvidBiotics Corp. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • AvidBiotics Corp., Key Information
  • AvidBiotics Corp., Key Facts
  • AvidBiotics Corp. - Pipeline by Indication, 2015
  • AvidBiotics Corp. - Pipeline by Stage of Development, 2015
  • AvidBiotics Corp. - Monotherapy Products in Pipeline, 2015
  • AvidBiotics Corp. - Preclinical, 2015
  • AvidBiotics Corp. - Discovery, 2015
  • AvidBiotics Corp. - Pipeline by Target, 2015
  • AvidBiotics Corp. - Pipeline by Molecule Type, 2015
  • AvidBiotics Corp. - Pipeline Products by Mechanism of Action, 2015
  • AvidBiotics Corp. - Recent Pipeline Updates, 2015

List of Figures

  • AvidBiotics Corp. - Pipeline by Top 10 Indication, 2015
  • AvidBiotics Corp. - Pipeline by Stage of Development, 2015
  • AvidBiotics Corp. - Monotherapy Products in Pipeline, 2015
  • AvidBiotics Corp. - Pipeline by Top 10 Target, 2015
  • AvidBiotics Corp. - Pipeline by Top 10 Molecule Type, 2015
  • AvidBiotics Corp. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top